Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: In vitro biological evaluation and in silico docking

60Citations
Citations of this article
73Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A convenient and efficient new method has been established for the synthesis of dihydropyrimidines by inexpensive and non-toxic N-acetyl glycine (NAG) catalysed reaction of aromatic aldehydes with ethyl acetoacetate and urea/thiourea. This method is applicable for various substituted aldehydes as well as urea and thiourea. It has also been used to synthesize bicyclic oxygen-bridged pyrimidine derivatives (4d, 4j). The biological assay revealed that the majority of compounds synthesized displayed modest inhibitory activity against α-glucosidase at low micro-molar concentrations. Molecular docking studies were also performed on the most active compound, 4f (with IC 50 value 112.21 ± 0.97 μM), to show the enzyme - inhibitor interactions. © 2014 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Yar, M., Bajda, M., Shahzadi, L., Shahzad, S. A., Ahmed, M., Ashraf, M., … Khan, A. F. (2014). Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: In vitro biological evaluation and in silico docking. Bioorganic Chemistry, 54, 96–104. https://doi.org/10.1016/j.bioorg.2014.05.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free